Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round. The company develops monoclonal antibodies for oral administration to en
You are here
News
News
27.10.20
21.10.20
ViroVet nv, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce that it has successfully confirmed t
10.09.20
Recognition of Biotalys' unique protein-based biocontrol solutions for food protection.
09.07.20
Strenghtening Executive Management Team with international financial leadership